Elyxium Wealth’s Ultragenyx Pharmaceutical RARE Stock Holding History

Elyxium Wealth’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$691	Buy	+46	New	+$1.1K	﹤0.01%	1400

Other funds holding RARE

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

Crestwood Advisors Group Boston, Massachusetts $6.76B AUM 24% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Apollon Wealth Management Mount Pleasant, South Carolina $8.72B AUM 23.07% 1-Year Est. Return

L. Roy Papp & Associates Phoenix, Arizona $981M AUM 26.21% 1-Year Est. Return

Motley Fool Asset Management Alexandria, Virginia $2.64B AUM 26.58% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Elyxium Wealth's RARE Position: Q3 2026 in Review

Elyxium Wealth opened a new position in Ultragenyx Pharmaceutical (RARE) in Q3 2026: 46 shares worth $691. The stake represents ﹤0.01% of the portfolio and ranks #1400 among its holdings.

35 funds tracked by Wall St. Rank hold RARE as of Q3 2026.

Elyxium Wealth held 46 shares of Ultragenyx Pharmaceutical worth $691 as of Q3 2026.
Ultragenyx Pharmaceutical was a new Elyxium Wealth position in Q3 2026.
Ultragenyx Pharmaceutical made up ﹤0.01% of Elyxium Wealth's portfolio in Q3 2026, its #1400 holding.
35 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.

Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.